Literature DB >> 17135454

Magnetic resonance perfusion diffusion mismatch, thrombolysis, and clinical outcome in acute stroke.

Angel Chamorro.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 17135454      PMCID: PMC2117839          DOI: 10.1136/jnnp.2006.108795

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.

Authors:  Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

2.  Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I.

Authors:  A Dávalos; D Toni; F Iweins; E Lesaffre; S Bastianello; J Castillo
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

Review 3.  Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date.

Authors:  I Kane; P Sandercock; J Wardlaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

Review 4.  Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome poststroke: A critical review of the literature.

Authors:  S K Schiemanck; G Kwakkel; M W M Post; A J H Prevo
Journal:  Neurorehabil Neural Repair       Date:  2006-12       Impact factor: 3.919

Review 5.  Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy.

Authors:  Geoffrey A Donnan; Stephen M Davis
Journal:  Lancet Neurol       Date:  2002-11       Impact factor: 44.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.